• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经转子旋转截骨术治疗非创伤性股骨头坏死的长期疗效

Long-term outcomes of transtrochanteric rotational osteotomy for non-traumatic osteonecrosis of the femoral head.

作者信息

Morita D, Hasegawa Y, Okura T, Osawa Y, Ishiguro N

机构信息

Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya City 466-8550, Japan.

出版信息

Bone Joint J. 2017 Feb;99-B(2):175-183. doi: 10.1302/0301-620X.99B2.BJJ-2016-0417.R2.

DOI:10.1302/0301-620X.99B2.BJJ-2016-0417.R2
PMID:28148658
Abstract

AIMS

Transtrochanteric rotational osteotomy (TRO) is performed for young patients with non-traumatic osteonecrosis of the femoral head (ONFH) to preserve the hip. We aimed to investigate the long-term outcomes and the risk factors for failure 15 years after this procedure.

PATIENTS AND METHODS

This study included 95 patients (111 hips) with a mean age of 40 years (21 to 64) who underwent TRO for ONFH. The mean follow-up was 18.2 years (3 to 26). Kaplan-Meier survivorship analyses were performed with conversion to total hip arthroplasty (THA) and radiological failure due to secondary collapse of the femoral head or osteoarthritic changes as the endpoint. Multivariate analyses were performed to assess risk factors for each outcome.

RESULTS

Survival rates at 15 years with conversion to THA and radiological failure as the endpoint were 59% (95% confidence interval (CI) 49 to 67) and 30% (95% CI 22 to 39), respectively. Necrotic type C2 ONFH (lesions extending laterally to the acetabular edge) (hazards ratio (HR) 3.9) and age > 40 years (HR 2.5) were risk factors for conversion to THA. Stage > 3a ONFH (HR 2.0) and age > 40 years (HR 1.9) were risk factors for radiological failure.

CONCLUSION

The 15 year outcomes after TRO for ONFH are unfavorable because osteoarthritic changes occur after five years post-operatively. Cite this article: Bone Joint J 2017;99-B:175-83.

摘要

目的

对于非创伤性股骨头坏死(ONFH)的年轻患者,施行转子间旋转截骨术(TRO)以保留髋关节。我们旨在研究该手术后15年的长期疗效及失败的危险因素。

患者与方法

本研究纳入了95例(111髋)平均年龄40岁(21至64岁)因ONFH接受TRO的患者。平均随访时间为18.2年(3至26年)。采用Kaplan-Meier生存分析,以转换为全髋关节置换术(THA)以及因股骨头继发塌陷或骨关节炎改变导致的影像学失败作为终点。进行多因素分析以评估各结局的危险因素。

结果

以转换为THA和影像学失败为终点的15年生存率分别为59%(95%置信区间(CI)49至67)和30%(95%CI 22至39)。坏死C2型ONFH(病变外侧延伸至髋臼边缘)(风险比(HR)3.9)和年龄>40岁(HR 2.5)是转换为THA的危险因素。ONFH分期>3a期(HR 2.0)和年龄>40岁(HR 1.9)是影像学失败的危险因素。

结论

ONFH行TRO术后15年的疗效不佳,因为术后五年会出现骨关节炎改变。引用本文:《骨与关节杂志》2017年;99-B:175 - 83。

相似文献

1
Long-term outcomes of transtrochanteric rotational osteotomy for non-traumatic osteonecrosis of the femoral head.经转子旋转截骨术治疗非创伤性股骨头坏死的长期疗效
Bone Joint J. 2017 Feb;99-B(2):175-183. doi: 10.1302/0301-620X.99B2.BJJ-2016-0417.R2.
2
Effects of age and body mass index on the results of transtrochanteric rotational osteotomy for femoral head osteonecrosis.年龄和体重指数对股骨头坏死转子间旋转截骨术结果的影响。
J Bone Joint Surg Am. 2010 Feb;92(2):314-21. doi: 10.2106/JBJS.H.01020.
3
Effects of age and body mass index on the results of transtrochanteric rotational osteotomy for femoral head osteonecrosis: surgical technique.年龄和体重指数对股骨头坏死转子间旋转截骨术结果的影响:手术技术。
J Bone Joint Surg Am. 2011 Mar;93 Suppl 1:75-84. doi: 10.2106/JBJS.J.01215.
4
Comparison of Surgical Parameters and Results between Curved Varus Osteotomy and Rotational Osteotomy for Osteonecrosis of the Femoral Head.股骨头坏死的弧形内翻截骨术与旋转截骨术的手术参数及结果比较
Clin Orthop Surg. 2017 Jun;9(2):160-168. doi: 10.4055/cios.2017.9.2.160. Epub 2017 May 8.
5
Outcome of transtrochanteric rotational osteotomy for posttraumatic osteonecrosis of the femoral head with a mean follow-up of 12.3 years.经转子旋转截骨术治疗创伤后股骨头坏死的疗效,平均随访12.3年。
Arch Orthop Trauma Surg. 2015 Sep;135(9):1257-63. doi: 10.1007/s00402-015-2282-y. Epub 2015 Jul 15.
6
Progressive collapse of transposed necrotic area after transtrochanteric rotational osteotomy for osteonecrosis of the femoral head induces osteoarthritic change. Mid-term results of transtrochanteric rotational osteotomy for osteonecrosis of the femoral head.经转子旋转截骨术治疗股骨头坏死时,移位坏死区域的渐进性塌陷会引发骨关节炎改变。经转子旋转截骨术治疗股骨头坏死的中期结果。
Arch Orthop Trauma Surg. 2004 Mar;124(2):77-81. doi: 10.1007/s00402-003-0610-0. Epub 2003 Dec 5.
7
Total Hip Arthroplasty After Transtrochanteric Rotational Osteotomy for Osteonecrosis of the Femoral Head: A Mean 10-Year Follow-Up.髋关节置换术治疗股骨头坏死转子间旋转截骨术后:平均 10 年随访。
J Arthroplasty. 2017 Oct;32(10):3088-3092. doi: 10.1016/j.arth.2017.05.020. Epub 2017 May 18.
8
Evaluation of the long-term patient-reported outcomes after hip arthroplasty or joint preserving with Sugioka femoral osteotomy in patients with femoral head osteonecrosis.评估股骨头坏死患者行髋关节置换或 Sugioka 股骨截骨保关节手术后的长期患者报告结局。
Int Orthop. 2024 May;48(5):1201-1208. doi: 10.1007/s00264-024-06118-3. Epub 2024 Feb 20.
9
Conversion total hip arthroplasty after previous transtrochanteric rotational osteotomy for osteonecrosis of the femoral head.全髋关节翻修术治疗股骨头坏死股骨转子间旋转截骨术后。
J Arthroplasty. 2014 Apr;29(4):813-6. doi: 10.1016/j.arth.2013.09.012. Epub 2013 Oct 9.
10
Hip survival rate in the patients with avascular necrosis of femoral head after transtrochanteric rotational osteotomy: a systematic review and meta-analysis.转子间旋转截骨术后股骨头缺血性坏死患者的髋关节存活率:系统评价和荟萃分析。
Chin Med J (Engl). 2019 Dec 20;132(24):2960-2971. doi: 10.1097/CM9.0000000000000562.

引用本文的文献

1
The Role of Proximal Femoral Osteotomy for the Treatment of Avascular Necrosis: A Systematic Review of Clinical and Patient-Reported Outcomes.股骨近端截骨术在治疗股骨头缺血性坏死中的作用:对临床和患者报告结局的系统评价
J Clin Med. 2025 Aug 7;14(15):5592. doi: 10.3390/jcm14155592.
2
Advances in mechanism and management of bone homeostasis in osteonecrosis: a review article from basic to clinical applications.骨坏死中骨稳态的机制与管理进展:一篇从基础到临床应用的综述文章
Int J Surg. 2025 Jan 1;111(1):1101-1122. doi: 10.1097/JS9.0000000000002094.
3
Recent trends of stem cell therapies in the management of orthopedic surgical challenges.
干细胞疗法在应对骨科手术挑战中的最新趋势。
Int J Surg. 2024 Oct 1;110(10):6330-6344. doi: 10.1097/JS9.0000000000001524.
4
Development of a risk-predicting score for hip preservation with bone grafting therapy for osteonecrosis.用于骨坏死保髋植骨治疗的风险预测评分系统的开发。
iScience. 2024 Feb 27;27(4):109332. doi: 10.1016/j.isci.2024.109332. eCollection 2024 Apr 19.
5
Evaluation of the long-term patient-reported outcomes after hip arthroplasty or joint preserving with Sugioka femoral osteotomy in patients with femoral head osteonecrosis.评估股骨头坏死患者行髋关节置换或 Sugioka 股骨截骨保关节手术后的长期患者报告结局。
Int Orthop. 2024 May;48(5):1201-1208. doi: 10.1007/s00264-024-06118-3. Epub 2024 Feb 20.
6
Total Hip Arthroplasty After Failed Hip-Preserving Surgery with Concentrated Autologous Bone Marrow Aspirate Transplantation for Osteonecrosis of the Femoral Head: A Retrospective Study.股骨头坏死保髋手术失败后采用浓缩自体骨髓抽吸物移植进行全髋关节置换术:一项回顾性研究
Indian J Orthop. 2022 Feb 1;56(7):1251-1258. doi: 10.1007/s43465-022-00603-w. eCollection 2022 Jul.
7
Treatment of non-traumatic avascular necrosis of the femoral head (Review).非创伤性股骨头缺血性坏死的治疗(综述)
Exp Ther Med. 2022 May;23(5):321. doi: 10.3892/etm.2022.11250. Epub 2022 Mar 10.
8
Clinical Outcome of Free Vascularized Fibula Graft for Nonunion of Garden IV Femoral Neck Fracture of 13 Years Duration: A Case Report.游离腓骨移植治疗Garden IV 型股骨颈骨折骨不连 13 年的临床疗效:病例报告。
Orthop Surg. 2022 Apr;14(4):775-781. doi: 10.1111/os.13154. Epub 2022 Mar 29.
9
Bone Regeneration and Angiogenesis by Co-transplantation of Angiotensin II-Pretreated Mesenchymal Stem Cells and Endothelial Cells in Early Steroid-Induced Osteonecrosis of the Femoral Head.骨再生和血管生成通过共移植预处理的间充质干细胞和内皮细胞血管紧张素 II 在早期类固醇诱导的股骨头坏死。
Cell Transplant. 2022 Jan-Dec;31:9636897221086965. doi: 10.1177/09636897221086965.
10
Bone Marrow Mesenchymal Stem Cells Overexpressing HIF-1α Prevented the Progression of Glucocorticoid-Induced Avascular Osteonecrosis of Femoral Heads in Mice.过表达缺氧诱导因子-1α的骨髓间充质干细胞可预防小鼠糖皮质激素诱导的股骨头缺血性坏死进展。
Cell Transplant. 2022 Jan-Dec;31:9636897221082687. doi: 10.1177/09636897221082687.